How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
NCT03322254 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-01-23
Summary
Reviewing providers' current standard operating procedure on Respiratory Pathogen testing
Conditions
- Respiratory Disease
Interventions
- OTHER
-
respiratory pathogen panel
lab testing for respiratory pathogens
Sponsors & Collaborators
-
PAS Research Services
collaborator OTHER -
Data Collection Analysis Business Management
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-24
- Primary Completion
- 2020-10-24
- Completion
- 2020-11-01
Countries
- United States
Study Locations
More Related Trials
-
Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults
NCT03534622 ·Status: COMPLETED ·Phase: PHASE1
-
Pattern and Outcomes of Chest Diseases
NCT06053528 ·Status: UNKNOWN
-
Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support
NCT04255303 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate
NCT04358419 ·Status: COMPLETED
-
Implementing a Combination of Clinical Parameters, Biomarkers and SoCs for the Etiology Diagnoses of Pneumonia in Pediatric Patients
NCT03366454 ·Status: COMPLETED
-
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
NCT05568654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of the Effectiveness of a Prototype Diagnostic System of Bacterial Respiratory Infections Based on Real-time Sequencing
NCT07303400 ·Status: ACTIVE_NOT_RECRUITING
-
Point of Care Polymerase Chain Reaction (PCR) Diagnostics of Respiratory Tract Infections in General Practice
NCT06120153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test
NCT02018198 ·Status: COMPLETED
-
Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia
NCT03711227 ·Status: COMPLETED
-
Non Invasive Diagnosis of Pneumocystis Pneumonia
NCT03613025 ·Status: COMPLETED ·Phase: NA
-
A Sputum Screening Test to Rule-out Pneumonia at an Early Stage
NCT03256604 ·Status: COMPLETED
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.
NCT01224977 ·Status: UNKNOWN ·Phase: NA
-
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
NCT06055218 ·Status: COMPLETED
-
Evaluation the Association of Microbiome Between Respiratory Tract Samples and Stool Samples in Pneumonic Patients Accompanied by Respiratory Failure
NCT03379779 ·Status: COMPLETED
-
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001477 ·Status: COMPLETED
-
Actionable Results: Bloodstream Infection Molecular Assay Evaluation
NCT03255759 ·Status: COMPLETED ·Phase: NA
-
Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia
NCT05937126 ·Status: COMPLETED
-
Rapid Detection of Airway Pathogens for Lung Transplantation
NCT03933878 ·Status: COMPLETED
-
The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens
NCT07035535 ·Status: ENROLLING_BY_INVITATION
-
Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia
NCT00914550 ·Status: COMPLETED
-
Pneumococcal Carriage in Patients With Lower Respiratory Tract Infection (LRTI)
NCT01861184 ·Status: COMPLETED
-
Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
NCT05162534 ·Status: COMPLETED
-
Diagnostic Accuracy of Infection Biomarkers in the Initial Investigation of Patients With Suspected Pneumonia
NCT04652167 ·Status: COMPLETED
-
Pathogen Detection and Community Acquired Pneumonia
NCT02880384 ·Status: COMPLETED ·Phase: NA